Catherine Meyers, M.D.
Director, Office of Clinical and Regulatory Affairs
Catherine Meyers, M.D., is the Director of NCCAM’s Office of Clinical and Regulatory Affairs (OCRA), which plays a major role in the planning, coordinating, and monitoring of the clinical research program. She and her staff serve as a resource for NCCAM’s program staff and clinical investigators to facilitate safe implementation of NCCAM-funded clinical studies. In addition, OCRA oversees NCCAM-appointed Data and Safety Monitoring Boards and ensures regulatory compliance for NCCAM-initiated projects, including compliance with U.S. Food and Drug Administration (FDA) regulations.
Dr. Meyers earned her B.S. in chemistry at the University of Chicago and received her M.D. from the University of Illinois at Chicago. She completed postgraduate residency training in internal medicine at the University of Chicago (Michael Reese Hospital) and a clinical nephrology fellowship at the University of Pennsylvania, Philadelphia. She then completed a research nephrology fellowship in renal immunology at the University of Pennsylvania. Following her fellowship, she was a faculty member of the University of Pennsylvania’s School of Medicine for 7 years, with an appointment in the Department of Internal Medicine, Renal-Electrolyte and Hypertension Division. Dr. Meyers’s research program focused on characterizing mechanisms of immune-mediated kidney injury.
Prior to her 2009 arrival at NCCAM, Dr. Meyers had devoted nearly a decade of work focused on clinical research of end-stage kidney disease. After a 3-year tenure at the FDA, where she provided oversight for trials of products for extracorporeal therapies, Dr. Meyers joined the National Institutes of Health (NIH) in 2002 as a Senior Scientific Advisor within the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), where she was the Director of Renal Inflammatory Programs within the Kidney, Urology and Hematology Division. She also worked on several NIH projects, including the NIH Transplantation Research Coordinating Committee and was the co-chair of the NIDDK Clinical Studies Working Group.
Dr. Meyers’s research interests include autoimmune mechanisms of disease, chronic kidney disease, and hemodialysis vascular access inflammation. She is currently the lead project scientist for the NIH Common Fund Health Care Systems Research Collaboratory, a 5-year effort to conduct pragmatic clinical trials in partnership with clinical investigators and health care systems in the United States.